CMB International: With continued policy efforts, Bullish on the rebound of China Meheco Group's valuation.

Benefiting from overseas interest rate cuts and improvements in the domestic macro environment, the pharmaceutical sector, as a high-elasticity Industry, is expected to outperform the market in 2025.

Zhitong FinanceJan 8 03:34 ET

[Brokerage Focus] CMB International stated that the pharmaceutical industry is expected to outperform the market in 2025, benefiting from overseas interest rate cuts and improvements in the domestic macro environment.

Jinwu Finance News | Zh Xia International released a Research Report stating that on January 3, the General Office of the State Council issued the "Opinions on Deepening the Reform of Pharmaceutical and Medical Instruments Regulation to Promote High-Quality Development of the Pharmaceutical Industry." The policy mentions deepening the reform of the entire process of pharmaceutical and medical instruments regulation, accelerating the establishment of a unified national market in the field of pharmaceutical and medical instruments, creating an innovative ecosystem with Global competitiveness, and promoting the transition of China from a major pharmaceutical country to a strong pharmaceutical country. The policy aims for significant improvements in the quality and efficiency of the review and approval of Innovative Drugs and medical instruments by 2027, establishing a regulatory system that aligns with pharmaceutical innovation and industrial development. By 2035, the pharmaceutical industry will have...

King Wu Financial NewsJan 8 02:37 ET

WUXI BIO has once again divested overseas Assets! Merck takes over WUXI BIO's Ireland vaccine factory for 0.5 billion USD | Quick read announcement.

① WUXI BIO announced today that it will sell the Ireland vaccine factory to Merck for 0.5 billion USD; ② this vaccine factory was originally built to undertake Merck's vaccine contract manufacturing business; ③ not long ago, WUXI APPTEC also divested its WuXi ATU business in the USA and United Kingdom.

cls.cnJan 6 09:47 ET

Clinical Trials Outsourcing Market Focused Insights 2024-2029 With Charles River, IQVIA, ICON, Laboratory Corp of America, Syneos Health, Thermo Fischer Scientific, WuXi AppTec, and Paraxel Dominating - ResearchAndMarkets.com

BusinesswireJan 6 06:41 ET

Preclinical Medical Device Testing Services Market Outlook, 2025-2035 - Dominated by Charles River Laboratories Int'l, Eurofins Scientific, SGS, WuXi AppTec, and Pace Analytical Services

Yahoo FinanceJan 3 04:15 ET

Express News | BlackRock, Inc's Long Position in H Shares of WuXi AppTec Reduced to 5.33% on Dec 27 From 6.01% - HKEX

ReutersJan 2 04:25 ET